SNY Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio18.48Forward 8.48
EPS (TTM)$2.30-11.7% YoY
Profit margin16.0%HEALTHCARE
Market cap$101.74BLarge cap
Wall Street coverage
$55.90median target· current $46.85 (+19.3%)10 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 8.48
- PEG ratio
- 3.69
- P/B
- 1.21
- P/S (TTM)
- 2.15
- EV/EBITDA
- 12.21
Profitability & growth
- ROE (TTM)
- 6.6%
- Operating margin
- 20.0%
- Revenue growth YoY
- 6.0%
- Dividend yield
- 0.0%
- Beta
- 0.28
Last earnings
Apr 23, 2026 · Estimate $1.03 · Reported $1.10
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Sanofi ADR
Company profileSanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Classification
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 46, AVENUE DE LA GRANDE ARMEE, PARIS
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$101.74B
Shares outstanding$2.39B
52W high$49.91
52W low$41.04
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent